ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 70.1

Change

+0.02 (+0.03)%

Market Cap

CAD 0.26B

Volume

3.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-04 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.30 (-0.71%)

CAD 3.04B
ZWU:CA BMO Covered Call Utilities ETF

-0.07 (-0.64%)

CAD 1.92B
XIT:CA iShares S&P/TSX Capped Informa..

-0.08 (-0.14%)

CAD 0.66B
TXF:CA First Asset Tech Giants Covere..

-0.05 (-0.21%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

N/A

CAD 0.64B
XHC:CA iShares Global Healthcare (CAD..

-0.49 (-0.68%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.02 (+0.09%)

CAD 0.55B
CWW:CA iShares Global Water Common Cl..

-0.32 (-0.55%)

CAD 0.33B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.10 (-0.36%)

CAD 0.33B
COW:CA iShares Global Agriculture Com..

+0.46 (+0.72%)

CAD 0.28B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.82% 17% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.82% 17% F 27% F
Trailing 12 Months  
Capital Gain 13.43% 40% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.43% 40% F 43% F
Trailing 5 Years  
Capital Gain 26.90% 37% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.90% 37% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 4.54% 31% F 51% F
Dividend Return 4.92% 26% F 49% F
Total Return 0.38% 28% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 16.33% 63% D 52% F
Risk Adjusted Return 30.11% 29% F 48% F
Market Capitalization 0.26B 71% C- 50% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.